Twist Bioscience Corporation (TWST) News

Twist Bioscience Corporation (TWST): $43.14

-3.85 (-8.19%)

POWR Rating

Component Grades













Add TWST to Watchlist
Sign Up

Industry: Biotech


of NR

in industry

Filter TWST News Items

TWST News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

TWST News Highlights

  • For TWST, its 30 day story count is now at 5.
  • Over the past 18 days, the trend for TWST's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • DNA, DECK and GENE are the most mentioned tickers in articles about TWST.

Latest TWST News From Around the Web

Below are the latest news stories about Twist Bioscience Corp that investors may wish to consider to help them evaluate TWST as an investment opportunity.

Twist Bioscience Corporation 2022 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Twist Bioscience Corporation in conjunction with their 2022 Q1 earnings call....

SA Transcripts on Seeking Alpha | February 17, 2022

IRadimed, Meridian Bioscience top healthcare gainers; Lannett, Vanda among losers

Gainers: IRadimed (NASDAQ:IRMD) +8%. Meridian Bioscience (NASDAQ:VIVO) +8%. Biofrontera (NASDAQ:BFRI) +6%. Inspira Technologies Oxy (NASDAQ:IINN) +6%. Taysha Gene Therapies (NASDAQ:TSHA) +5%. Losers: Lannett Company (NYSE:LCI) -24%. Vanda Pharmaceuticals (NASDAQ:VNDA) -22%. Evotec (NASDAQ:EVO) -14%. Syros Pharmaceuticals (NASDAQ:SYRS) -8%. Twist Bioscience (NASDAQ:TWST) -5%....

Seeking Alpha | February 4, 2022

Twist Bioscience's (TWST) CEO Emily Leproust on Q1 2022 Results - Earnings Call Transcript

Twist Bioscience Corporation (TWST) Q1 2022 Earnings Conference Call February 4, 2022 8:00 AM ET Company Participants Angela Bitting – Senior Vice President-Corporate Affairs and Chief ESG Officer Emily Leproust – Chief Executive Officer and Co-Founder Jim Thorburn – Chief Financial Officer Conference Call Participants Catherine Schulte – Baird Casey...

SA Transcripts on Seeking Alpha | February 4, 2022

Twist Bioscience: A Declining Biotech Company Headed For A Rebound

Twist Bioscience (NASDAQ: TWST) has emerged more recently as one of the leading biotech firms working with DNA. Headquartered in San Francisco, Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. Their mission far exceeds just medical research. By mastering the process of synthesizing DNA and...

A Kashyap on Seeking Alpha | January 30, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5139 seconds.